[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

MX163401B - Un procedimiento para preparar pseudomonato calcico cristalino o un hidrato del mismo - Google Patents

Un procedimiento para preparar pseudomonato calcico cristalino o un hidrato del mismo

Info

Publication number
MX163401B
MX163401B MX6897A MX689785A MX163401B MX 163401 B MX163401 B MX 163401B MX 6897 A MX6897 A MX 6897A MX 689785 A MX689785 A MX 689785A MX 163401 B MX163401 B MX 163401B
Authority
MX
Mexico
Prior art keywords
hydrate
procedure
crystalline calcium
preparing crystalline
calcium pseudomonate
Prior art date
Application number
MX6897A
Other languages
English (en)
Inventor
Geoffrey Harold Baker
Merle Beal
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10562629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MX163401(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of MX163401B publication Critical patent/MX163401B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • General Chemical & Material Sciences (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Electroluminescent Light Sources (AREA)
  • Seasonings (AREA)
  • Cosmetics (AREA)
MX6897A 1984-06-19 1985-06-18 Un procedimiento para preparar pseudomonato calcico cristalino o un hidrato del mismo MX163401B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848415579A GB8415579D0 (en) 1984-06-19 1984-06-19 Compounds

Publications (1)

Publication Number Publication Date
MX163401B true MX163401B (es) 1992-05-11

Family

ID=10562629

Family Applications (1)

Application Number Title Priority Date Filing Date
MX6897A MX163401B (es) 1984-06-19 1985-06-18 Un procedimiento para preparar pseudomonato calcico cristalino o un hidrato del mismo

Country Status (27)

Country Link
US (5) US4916155A (es)
EP (1) EP0167856B1 (es)
JP (1) JPH0723373B2 (es)
KR (1) KR930002509B1 (es)
AT (1) ATE49600T1 (es)
AU (1) AU577595B2 (es)
CA (1) CA1242437A (es)
DE (1) DE3575428D1 (es)
DK (1) DK164506C (es)
ES (1) ES8604249A1 (es)
FI (2) FI84179C (es)
GB (1) GB8415579D0 (es)
GR (1) GR851470B (es)
HU (1) HU195515B (es)
IE (1) IE58118B1 (es)
IL (1) IL75536A (es)
JO (1) JO1420B1 (es)
MX (1) MX163401B (es)
MY (1) MY102549A (es)
NO (1) NO171593C (es)
NZ (1) NZ212433A (es)
PH (1) PH22951A (es)
PL (1) PL254033A1 (es)
PT (1) PT80657B (es)
YU (1) YU45724B (es)
ZA (1) ZA854549B (es)
ZM (1) ZM4185A1 (es)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
GB8530796D0 (en) * 1985-12-13 1986-01-22 Beecham Group Plc Pharmaceutical composition
IE59628B1 (en) * 1986-06-26 1994-03-09 Beecham Group Plc Treatment of fungal infections
US5273998A (en) * 1990-05-11 1993-12-28 Yoshitomi Pharmaceutical Industries, Ltd. Process for making an optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compound
GB9507825D0 (en) * 1995-04-18 1995-05-31 Wet Pieter M De Method of treatment
GB9616208D0 (en) 1996-08-01 1996-09-11 Smithkline Beecham Plc Novel Compounds
CO4910145A1 (es) 1996-10-01 2000-04-24 Smithkline Beecham Corp Uso
BR9711843A (pt) * 1996-10-01 2001-07-31 Smithkline Beecham Corp Uso de mupirocina para a fabricação de um medicamento para o tratamento de infecções bacterianas associadas com colonização da nasofaringe por organimos patogênicos
GB9808470D0 (en) * 1998-04-22 1998-06-17 Smithkline Beecham Plc Novel process and apparatus
KR20010113674A (ko) * 1999-02-03 2001-12-28 자노스 바르가, 테레지아 밀레 미생물적 방법에 의하여 슈도몬산 ａ 항생제를 제조하는방법
DE02744598T1 (de) * 2001-06-21 2005-03-31 Biogal Gyogyszergyar Rt. Metabolisches kontrolliertes fermentationsverfahren zur herstellung von pseudomoninsäure
AU2002365431A1 (en) * 2001-12-28 2003-09-02 Teva Gyogyszergyar Reszvenytarsasag Processes for preparing crystalline and amorphous mupirocin calcium
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
AU2004258821A1 (en) * 2003-05-01 2005-02-03 Replidyne, Inc. Antibacterial methods and compositions
MXPA06010084A (es) * 2004-06-01 2007-03-01 Teva Gyogyszergyar Zartkoruen Proceso para la preparacion de forma amorfa de un farmaco.
AU2006215708B2 (en) * 2005-02-21 2011-01-27 Syngen Biotech Co., Ltd Purification of mupirocin
AU2006242824B2 (en) * 2005-05-03 2012-03-29 Ranbaxy Laboratories Limited Antimicrobial agents
US20070027046A1 (en) * 2005-08-01 2007-02-01 The Lubrizol Corporation Novel Dispersants
GB2441328A (en) * 2006-08-30 2008-03-05 Alpharma Aps A method for obtaining mupirocin calcium
US20110015413A1 (en) * 2008-01-24 2011-01-20 Nafis Defterdarovic Process for preparing crystalline calcium mupirocin dihydrate
WO2010132833A1 (en) * 2009-05-14 2010-11-18 The Regents Of The University Of Michigan Streptococcus vaccine compositions and methods of using the same
WO2012014109A1 (en) 2010-07-30 2012-02-02 Ranbaxy Laboratories Limited Heterocyclic sulfonamides as inhibitors of transfer rna synthetase for use as antibacterial agents
WO2016133471A1 (en) 2015-02-20 2016-08-25 Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş. A topical composition comprising mupirocin and dexpanthenol
KR102101297B1 (ko) 2019-02-15 2020-05-26 주식회사 드림테크 급속 스팀 세척기 제어방법
KR102269617B1 (ko) 2020-10-27 2021-06-24 신현호 스팀 급속제조장치 및 그 제어방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1395907A (en) * 1971-06-12 1975-05-29 Beecham Group Ltd Antibiotics
US4071536A (en) * 1971-06-12 1978-01-31 Beecham Group Limited Antibiotics
GB1587058A (en) * 1976-06-15 1981-03-25 Beecham Group Ltd Oxiranylmethyltetrahydropyran derivatives
GB1577730A (en) * 1976-10-23 1980-10-29 Beecham Group Ltd Treatment of infections with pseudomonicacid salts or esters thereof
GB1577545A (en) * 1977-07-27 1980-10-22 Beecham Group Ltd Treatment of swine dysenter
CA1115699A (en) * 1978-05-20 1982-01-05 Alan D. Curzons Lithium pseudomonate and its preparation
GB2097670B (en) * 1981-03-11 1985-02-27 Beecham Group Ltd Growth promotor containing pseudomonic acid
GB8313035D0 (en) * 1983-05-12 1983-06-15 Beecham Group Plc Compound
GB8415579D0 (en) * 1984-06-19 1984-07-25 Beecham Group Plc Compounds
US4892960A (en) * 1985-01-28 1990-01-09 International Minerals & Chemical Corp. Crystalline lysocellin compositions and method of making

Also Published As

Publication number Publication date
IL75536A0 (en) 1986-01-31
IE851506L (en) 1985-12-19
NO171593C (no) 1993-04-07
CA1242437A (en) 1988-09-27
DK164506B (da) 1992-07-06
JPS6117583A (ja) 1986-01-25
PL254033A1 (en) 1986-04-22
FI852407L (fi) 1985-12-20
FI84179B (fi) 1991-07-15
GR851470B (es) 1985-11-25
US5569672A (en) 1996-10-29
KR930002509B1 (ko) 1993-04-03
NO171593B (no) 1992-12-28
DK164506C (da) 1992-11-23
HUT38654A (en) 1986-06-30
PT80657B (en) 1987-05-04
FI84179C (fi) 1991-10-25
US4916155A (en) 1990-04-10
US5436266A (en) 1995-07-25
PT80657A (en) 1985-07-01
US5792790A (en) 1998-08-11
FI852407A0 (fi) 1985-06-17
DK275585D0 (da) 1985-06-18
AU577595B2 (en) 1988-09-29
ES544329A0 (es) 1986-01-16
GB8415579D0 (en) 1984-07-25
JPH0723373B2 (ja) 1995-03-15
KR860000291A (ko) 1986-01-27
PH22951A (en) 1989-02-03
IE58118B1 (en) 1993-07-14
FI88796C (fi) 1993-07-12
MY102549A (en) 1992-07-31
AU4373485A (en) 1986-01-02
FI913260A0 (fi) 1991-07-04
ES8604249A1 (es) 1986-01-16
NZ212433A (en) 1988-08-30
EP0167856A3 (en) 1986-11-26
EP0167856A2 (en) 1986-01-15
YU45724B (sh) 1992-07-20
FI88796B (fi) 1993-03-31
DK275585A (da) 1985-12-20
ZM4185A1 (en) 1985-11-22
ATE49600T1 (de) 1990-02-15
HU195515B (en) 1988-05-30
US5191093A (en) 1993-03-02
YU101385A (en) 1988-02-29
DE3575428D1 (de) 1990-02-22
IL75536A (en) 1989-01-31
EP0167856B1 (en) 1990-01-17
JO1420B1 (en) 1986-11-30
NO852446L (no) 1985-12-20
ZA854549B (en) 1986-05-28

Similar Documents

Publication Publication Date Title
MX163401B (es) Un procedimiento para preparar pseudomonato calcico cristalino o un hidrato del mismo
ATE69376T1 (de) Haarwuchsmittel.
HK1004257A1 (en) Use of droloxifene in the treatment of bone diseases
ES2038593T3 (es) Un procedimiento para preparar manosil-aglicona del antibiotico a 40926.
IL70438A (en) Azolyl-alkanol derivatives,their preparation and their use as microbicides and plant growth regulants
ES2001147A4 (es) Un procedimiento para la preparacion de una composicion farmaceutica que tiene actividad reguladora del calcio
HUT36783A (en) Process for preparing 1,7-diphenyl-3-methyl-aza-7-cyano-8-methyl-nonane
NO893256L (no) Fremgangsmaate for fremstilling av furyltiazolderivater.
IL84889A0 (en) Salts of pyrophosphorous acid,their preparation and their use as microbicides
ES2039436T3 (es) Un procedimiento para preparar una composicion farmaceutica.
ES460319A1 (es) Procedimiento para la obtencion de nuevos derivados de qui- noxalina-1,4-dioxido.
MX156014A (es) Procedimiento para preparar la sal de calcio del acido beta(4,5-difenil-oxasol-2-il) propionico
ZA886870B (en) L-dopa derivatives or their acid addition salts,process for producing same and their use
NO901765D0 (no) Bensement med cellevekststimulerende middel.